Form D · Biotechnology
Artelon, Inc.
Marietta, GA · CIK 0001978956
Offering snapshot reported Jun 2, 2023 · SEC filing
- Reported sold
- $20M Offering amount: $30M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 19, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 2, 2023 | Initial | $19,999,998 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-483204
Series B Preferred Stock; Common Stock issuable upon conversion
Source: Form D, filed Jun 2, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Greg Banker | Director |
| Steve Becker | Director |
| Gary Burbach | Director |
| Jeff Byrne | Executive |
| Mark Cohen | Director |
| Carter Meyer | Director |
| Kirk Nielsen | Director |
| Aaron Smith | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2150 Nw Parkway Se, Suite G
Marietta, GA, 30067
Marietta, GA, 30067